Cerus Corporation
CERS
#7725
Rank
A$0.49 B
Marketcap
A$2.59
Share price
-2.73%
Change (1 day)
13.33%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$17.29 Million, an increase over its 2023 earnings that were of -A$42.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-33.43%
2024 -A$17.29 Million-58.95%
2023 -A$42.1 Million-20.74%
2022 -A$53.12 Million-25.7%
2021 -A$71.49 Million-11.99%
2020 -A$81.23 Million-14%
2019 -A$94.45 Million21.73%
2018 -A$77.59 Million-0.65%
2017 -A$78.1 Million-10.96%
2016 -A$87.72 Million4.24%
2015 -A$84.15 Million50.99%
2014 -A$55.73 Million-10.08%
2013 -A$61.98 Million184.13%
2012 -A$21.82 Million-7.91%
2011 -A$23.69 Million
2009 -A$33.46 Million-24.69%
2008 -A$44.42 Million-25.2%
2007 -A$59.39 Million330.54%
2006 -A$13.8 Million1.49%
2005 -A$13.6 Million-61.02%
2004 -A$34.87 Million
2002 -A$86.25 Million10.02%
2001 -A$78.39 Million34.25%
2000 -A$58.4 Million61.02%
1999 -A$36.27 Million-18.81%
1998 -A$44.67 Million93.08%
1997 -A$23.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.92 B-46,873.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$21.26 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.36 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.81 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA